Delos Wealth Advisors’s AstraZeneca AZN Stock Holding History

Delos Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71K	Buy	+9	New	+$1.69K	﹤0.01%	280
2025 Q3	–	Sell	-27	Closed	-$3.77K	–	289
2025 Q2	$3.77K	Buy	+27	New	+$3.78K	﹤0.01%	214
2025 Q1	–	Sell	-27	Closed	-$3.54K	–	66
2024 Q4	$3.54K	Buy	+27	New	+$3.78K	﹤0.01%	149
2024 Q1	–	Sell	-7	Closed	-$943	–	359
2023 Q4	$943	Hold	7	–	–	﹤0.01%	194
2023 Q3	$950	Hold	7	–	–	﹤0.01%	227
2023 Q2	$1K	Hold	7	–	–	﹤0.01%	217
2023 Q1	$972	Hold	7	–	–	﹤0.01%	225
2022 Q4	$949	Hold	7	–	–	﹤0.01%	240
2022 Q3	$1K	Buy	+7	New	+$888	﹤0.01%	209

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Delos Wealth Advisors's AZN Position: Q2 2026 in Review

Delos Wealth Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 9 shares worth $1.71K. The stake represents ﹤0.01% of the portfolio and ranks #280 among its holdings. This is a return to the name: Delos Wealth Advisors previously reported a position in AZN as recently as Q2 2025.

Delos Wealth Advisors first reported a position in AZN in Q3 2022 and has held it in 9 quarters since. The position peaked at $3.77K in Q2 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Delos Wealth Advisors held 9 shares of AstraZeneca worth $1.71K as of Q2 2026.
AstraZeneca was a new Delos Wealth Advisors position in Q2 2026.
AstraZeneca made up ﹤0.01% of Delos Wealth Advisors's portfolio in Q2 2026, its #280 holding.
Delos Wealth Advisors first reported a position in AstraZeneca in Q3 2022 and has held it in 9 quarters since.
Delos Wealth Advisors's AstraZeneca position peaked at $3.77K in Q2 2025.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.